Definition
AI for drug repurposing refers to the use of artificial intelligence technologies, including machine learning, natural language processing, and predictive analytics, to identify new therapeutic uses for existing drugs. This approach accelerates drug discovery by analyzing vast datasets, identifying potential drug-disease interactions, and reducing the cost and time required for research and development.
Get Research Report Sample & TOC: Get Insights
Key Trends
- Integration of Big Data and AI: The combination of AI and big data analytics is enabling researchers to mine extensive biomedical datasets, uncovering hidden connections between drugs and diseases.
- Advancements in Predictive Modeling: The development of advanced AI algorithms is improving the accuracy of predictions for drug efficacy and safety in new indications.
- Increased Focus on Rare Diseases: AI-driven drug repurposing is gaining traction in addressing rare diseases, where traditional drug discovery methods are often cost-prohibitive.
- Collaborations Between Tech and Pharma: Partnerships between AI-focused tech companies and pharmaceutical giants are accelerating innovation and expanding the scope of AI applications in drug repurposing.
- COVID-19 Impact: The pandemic highlighted the potential of AI in rapidly identifying repurposed drugs, spurring investments and research in this area.
Inquiry before Buying: Request Special Pricing
Key Drivers
- Cost Efficiency in Drug Development: Repurposing existing drugs reduces the need for extensive clinical trials, cutting costs and time significantly compared to developing new drugs from scratch.
- Growing Computational Power: Advances in AI infrastructure, such as cloud computing and high-performance GPUs, are enabling more complex analyses and faster processing.
- Demand for Personalized Medicine: AI is helping to identify specific patient populations that may benefit most from repurposed drugs, aligning with the trend toward precision medicine.
- Regulatory Support: Regulatory bodies are increasingly supportive of drug repurposing initiatives, providing incentives and streamlined pathways for approval.
- Rising Healthcare Costs: The need to control healthcare expenditures is driving the adoption of cost-effective drug repurposing strategies powered by AI.
Key Players
- BenevolentAI
- Insilico Medicine
- Atomwise, Inc.
- Exscientia
- Healx
- Recursion Pharmaceuticals
- BioXcel Therapeutics
- Verge Genomics
- GNS Healthcare
- IBM Watson Health
Procure Complete Report (300 Pages PDF with Insights, Charts, Tables, and Figures) @ Buy Now
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with the lead analyst of the report
- Infographic Excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after-sales service
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with the highest-quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/